MedTrace Logo

A Clinical Trial Evaluating the Influence of the Ingredients MyCondro™ and Bovine Chondroitin Sulfate on the Behavior of Cells in the Osteoarticular Sphere

NCT07727174 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-07-27

No results posted yet for this study

Summary

The study evaluates the effect of chondroitin sulfate derived from fermentation (MyCondro™) and bovine chondroitin sulfate, on the health and function of the skeletal system ex vivo, including cartilage, joint capsule, and bone tissue. The primary aim of the study is to determine the influence of human sera enriched with metabolites resulting from the ingestion of the ingredients on the metabolism of human primary cells of cartilage (chondrocytes), joint capsule (synoviocytes) and bone tissue (osteoblasts). Furthermore, the absorption kinetics of MyCondro™ and Bovine CS will be described.

Conditions

  • Joint Health

Interventions

DIETARY_SUPPLEMENT

MyCondro™

This is a non-animal chondroitin sulfate

DIETARY_SUPPLEMENT

Bovine chondroitin sulfate

This is animal-derived chondroitin of bovine origin

Sponsors & Collaborators

  • Clinic'n'Cell

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Lesaffre International

    lead INDUSTRY

Principal Investigators

  • Gisèle PICKERING · Head of Department - Investigation Platform Clinical - CHU Clermont-Ferrand Clinical Investigation Center, Inserm CIC

  • Yohann Wittrant · Scientific Coordinator Clinic'n'Cell - Faculty of Medicine and Pharmacy - Clermont-Ferrand - France

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-26
Primary Completion
2026-12-08
Completion
2027-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07727174 on ClinicalTrials.gov